Observational studyJournal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus2021
A prospective study of treatments for adult-onset divergence insufficiency-type esotropia.
Observational study in Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02510040 (A Prospective Observational Study of Adult Strabismus), which is not on this map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective Observational Study of Adult Strabismus
Who cites it
8 citing papers in PubMed, 14 citations in OpenAlex.
- Association Between Strabismus and Risk of Open-Angle Glaucoma: A Multicenter Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Convergence Insufficiency After Bilateral Medial Rectus Recession for Age-Related Distance Esotropia?American journal of ophthalmology · 2026Article
- Virtual Reality-Based Screening Tool for Distance Horizontal Fusional Vergence in Orthotropic Young Subjects: A Prospective Pilot Study.Life (Basel, Switzerland) · 2025Article
- The difference in clinical features of acute acquired concomitant esotropia between adolescents and adults: a prospective observational cohort study.Scientific reports · 2025Observational
- 2021 trends in the treatment of patients with strabismus in Japan.Japanese journal of ophthalmology · 2025Article
- Doses of medial rectus muscle recessions for divergence insufficiency-type esotropia.Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus · 2024Article
- Quotidian Profile of Vergence Angle in Ambulatory Subjects Monitored With Wearable Eye Tracking Glasses.Translational vision science & technology · 2023Article
- Evaluation and Management of Divergence Insufficiency-Type Esotropia.Journal of binocular vision and ocular motilityArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 14 institutions in 1 country.
Funding
Abstract
purposeTo describe 10-week and 12-month outcomes following treatment for divergence insufficiency-type esotropia in adults.
methodsIn this prospective observational study, 110 adults with divergence insufficiency-type esotropia, with a distance esodeviation measuring 2
resultsOf the 110 participants, 32 (29%) were prescribed base-out prism; none had received prior treatment for esotropia. Success criteria were met by 22 of 30 at 10 weeks (73%; 95% CI, 54%-88%) and by 16 of 26 at 12 months (62%; 95% CI, 41%-80%). For the 76 (68%) who underwent strabismus surgery (82% of whom had been previously treated with prism), success criteria were met by 69 of 74 at 10 weeks (93%; 95% CI, 85%-98%) and by 57 of 72 at 12 months (79%; 95% CI, 68%-88%).
conclusionsIn this study cohort, both base-out prism as initial therapy and strabismus surgery (usually following prism) were successful in treating diplopia for most adults with divergence insufficiency-type esotropia when assessed during the first year of follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.